Test Research Inc
TWSE:3030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Test Research Inc
TWSE:3030
|
TW |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
F
|
Figeac Aero SARL
SWB:1F1
|
FR |
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
|
C
|
C29 Metals Ltd
ASX:C29
|
AU |
|
M
|
Myriad Genetics Inc
LSE:0K3W
|
US |
|
N
|
Neo Cremar Co Ltd
KOSDAQ:311390
|
KR |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
IN |
|
N
|
NXP Semiconductors NV
F:VNX
|
NL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Test Research Inc's stock price target?
Not Available
Test Research Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Test Research Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is 14%.
What is the Operating Income forecast for Test Research Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 1 year is 6%.